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Accumulating evidence suggests that dysfunction of T cells underlies the pathogenesis of systemic lupus erythematosus (SLE). We
revealed that SLE T cells produced an abnormally excessive amount of IFN-γ in vitro upon stimulation through TCR, and the
expression level of TCR zeta was signiﬁcantly reduced. The production of IFN-γ by SLE T cells was negatively correlated with the
expressionlevelofTCRzeta.ThiscorrelationwasabolishedwhenthecellswerestimulatedwithTPAandionomycin,whichbypass
TCR and introduce signals directly into the cells, but the production of IFN-γ by SLE T cells remained abnormally elevated. Taken
together, these data suggest that regulatory mechanisms not only for the expression of TCR zeta but also for the production of
IFN-γ were impaired in SLE T cells. These impairments may be responsible for the aberrant responses of SLE T cells and partly
involved in the development of SLE.
1.Introduction
Systemic lupus erythematosus (SLE) is an autoimmune
disease characterized by the production of a variety of
autoantibodies, which may readily form immune complexes
causing such disorders as lupus nephritis [1–3]. Several
lines of evidence have suggested that dysfunction of T
cells underlies the pathogenesis of the disease although
malfunction of B cells may be directly responsible for the
abnormal production of autoantibodies. For example, it has
been reported that IFN-α and IFN-γ produced by T cells
are implicated in the pathogenesis of SLE [4–7]. In addition,
serum levels of inﬂammatory cytokines including IFN-γ
and IL-6 were abnormally elevated in SLE patients [4, 7,
8]. Moreover, T cells from SLE patients showed excessive
production of cytokines in response to various stimuli in
vitro [9–15]. All of these data collectively imply possible
involvement of T cells in the pathogenesis of SLE.
We have previously reported that the expression of TCR
zeta is suppressed in peripheral T cells of patients aﬄicted
with SLE, and the expression level of TCR zeta is correlated
with some symptoms of the disease, such as butterﬂy rash
andvasculitis[16,17].Otherinvestigatorshavealsoobserved
reduced expression of TCR zeta in SLE T cells [18–20]. It
may be noteworthy that several SLE patients have a deletion
in exon 7 of the TCR zeta gene, which spans the GTP/GDP
binding site and a part of the third ITAM domain [21].
Taken together, it is postulated that the suppression of the
expression of TCR zeta and/or functional abnormalities of
TCR zeta in SLE T cells cause abnormal responses of T2 Journal of Biomedicine and Biotechnology
cells which in turn lead to aberrations of B cells. In the
presentstudy,weprovidedatasuggestingthatboththesignal
transduction cascade via TCR and the regulatory mechanism
of the expression of IFN-γ are impaired in T cells of SLE
patients.
2.MaterialsandMethods
2.1. Monoclonal Antibodies and Recombinant Human
Cytokines. Antibodies against CD3 (HIT3a), IL-2 (MQ1-
17H12 and B33-2), and IFN-γ (B27 and 4S.B3) were
purchased from BD Biosciences Pharmingen (San Diego,
USA.). An anti-TCR zeta antibody (TIA-2) was purchased
from Santa Cruz (Santa Cruz, USA.). Recombinant human
IL-2 and IFN-γ as the standards for ELISA were also
purchased from BD Biosciences Pharmingen.
2.2. Subjects. Venous blood samples were collected from
JapaneseSLEpatients(n=20,female,age19–49(averageage:
36.2)) who met the revised ACR classiﬁcation and healthy
individuals (n = 7, female, age 22–41 (average age: 34.4))
under informed consent. All the patients diagnosed were
clinically inactive when the samples were collected. This
study was approved by the Ethics Committee at Saitama
Medical University.
2.3. Cell Culture. Peripheral T cells were enriched by mix-
ing whole venous blood with RosetteSep T cell Enrich-
ment Cocktail (StemCell Technologies, Vancouver, Canada)
and separating cells with Ficoll-Hypaque (GE Healthcare,
Buckinghamshire, UK) density gradient centrifugation as
described previously in [22]. FACS analysis revealed that the
purity of the T cells was >90%.
2.4. Analysis of the Expression Level of TCR Zeta. The expres-
sionlevelofTCRzetainSLETcellswasanalyzedwithacom-
bination of immunoprecipitation and immunoblotting as
described previously in [16]. In brief, peripheral T cells were
suspended in a lysis buﬀer, and the lysate was mixed with an
anti-TCRzetaantibody,TIA-2.Aftercentrifugation,proteins
in the immunoprecipitate were separated through SDS-
polyacrylamide gel and transferred onto a PVDF membrane
ﬁlter (Millipore, Bedford, USA.) which was subsequently
probedwiththesameantibody.BandscorrespondingtoTCR
zeta were quantiﬁed, and the results were normalized against
the control.
2.5. Cell Culture and Quantiﬁcation of Cytokines. Peripheral
Tc e l l s( 5× 105) prepared from SLE patients and healthy
individuals were cultured in RPMI1640 medium supple-
mented with 10% FBS (JRH Biosciences, Lenexa, USA.) and
5 × 10
−5 M of 2-mercaptoethanol (Sigma-Aldrich, St. Louis,
USA.). For stimulation of the T cells through TCR, the
cells were seeded in 24-well plates previously coated with
10μg/mL of an anti-CD3 antibody and cultured at 7% CO2
and 37
◦C. For “polyclonal stimulation”, T cells were cultured
in 24-well plates under the same conditions in the presence
of 1μg/mL of TPA (Sigma-Aldrich, St. Louis, USA.) and
0.1μg/mL of ionomycin (Sigma-Aldrich, St. Louis, USA.).
The amounts of IL-2 and IFN-γ in the culture supernatants
were measured by ELISA. The data were normalized against
those for control T cells.
2.6. RT-PCR Analysis. T o t a lR N A sw e r ee x t r a c t e df r o m
cells using total RNA Extracting Kit (Sigma-Aldrich, St.
Louis, USA.). Twenty ng of total RNAs were subjected to
reverse transcription using ReverTra Dash (Toyobo, Tokyo,
Japan). For RT-PCR analysis, transcripts for IFN-γ and
GAPDH (glyceraldehyde 3-phosphate dehydrogenase) were
ampliﬁed using AdvanTaq DNA Polymerase (Clontech,
Palo Alto, USA.). The following primer set was synthesized
for IFN-γ:5  -atgaaatatacaagttstatcttggcttt (forward) and
5 -gatgctcttcgacctcgaaacagcat (reverse). A primer set for
GAPDH was purchased from Toyobo (Tokyo, Japan).
The reaction conditions were as follows: 30s at 94
◦Cf o r
denaturation and 1.5 minutes at 72
◦C for annealing and
primer extension (35 cycles). The resultant DNA fragments
were separated through a 1.5% agarose gel and stained with
cyber green.
3. Results
3.1. Cytokine Production by T Cells Stimulated through TCR.
In order to investigate possible functional abnormalities of
SLE T cells, we examined cellular responses against stimuli
throughTCR.Tothisend,TcellspreparedfromSLEpatients
(“SLE T cells”) and healthy individuals (“control T cells”)
were cultured in 24-well plates previously coated with an
anti-CD3 antibody, HIT3a, which introduces signals into T
cells through TCR and induces the production of IFN-γ and
IL-2bythecells.Basedonourpreviousexperiments,thecells
were cultured for 2 or 4 days for the maximal production
of IFN-γ or IL-2, respectively. Our preliminary experiments
revealed that the stimulatory eﬀect of the anti-CD3 antibody
in combination with an anti-CD28 antibody on peripheral
T cells was indistinguishable from the sole eﬀect of the
anti-CD3 antibody in the production of IL-2 and IFN-γ.
Therefore, we used only anti-CD3 antibody as a stimulus to
simplify the experiments.
The baseline productions of IFN-γ and IL-2 by both
control and SLE T cells were below the detection limit
without stimulation (data not shown). Stimulation of the
cells with the anti-CD3 antibody induced the production
of IFN-γ. SLE T cells produced a signiﬁcantly higher
amount of IFN-γ than control T cells under the employed
conditions (Figure 1). An irrelevant antibody did not induce
the production of IL-2 nor of IFN-γ (data not shown). These
results indicate that SLE T cells were “hyperactivated” by the
stimulation in the production of IFN-γ. On the other hand,
there was no signiﬁcant diﬀerence between SLE and control
T cells in the production of IL-2 although the cells produced
substantial amount of IL-2 upon stimulation (Figure 1).
3.2. Gene Expression of IFN-γ in T Cells. The abnormal
responses of SLE T cells were further analyzed by RT-

































Figure 1: Production of IFN- γ and IL-2 by T cells upon stimulation
with an anti-CD3 antibody. Peripheral T cells (5 × 105)f r o mS L E
patients (n = 20; open circles) and healthy individuals (n = 7;
ﬁlled circles) were cultured in 24-well plates previously coated with
10μg/mL of an anti-CD3 antibody for 2 (IFN-γ) or 4 (IL-2) days.
The amounts of IFN-γ and IL-2 in the supernatants were measured
by ELISA, and the data were normalized against those for the
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Figure 2: RT-PCR analysis of gene expression of IFN-γ upon
stimulation with an anti-CD3 antibody. Control T cells (Control)
and SLE T cells (SLE) were cultured in the presence (+CD3) or
absence (None) of stimulation. Twenty ng of total RNAs extracted
from the cells were subjected to RT-PCR for IFN-γ and GAPDH.
The resultant DNA fragments were separated through a 1.5%
agarose gel and stained with cyber green.
the anti-CD3 antibody only slightly induced the expression
of the IFN-γ gene (Figure 2; Control), a remarkable increase
in the expression was detected when SLE T cells were
stimulated with the antibody (Figure 2; SLE). These data,
along with the results in Figure 1, suggest that the induction
of the expression of the IFN-γ gene per se was responsible
for the excessive production of IFN-γ in stimulated SLE
T cells.
3.3. Relationship between the Expression Level of TCR Zeta
and IFN-γ Production. Our previous experiments revealed
that the expression of TCR zeta was suppressed in the
substantial number of SLE patients [16, 17]. In addition,
the expression level of TCR zeta was correlated with several
clinical manifestations of SLE [16]. These data prompted us
to investigate the relationship between the expression level of
TCR zeta and the production of IFN-γ in T cells.
The average of the relative expression level of TCR zeta
of SLE T cells from all of the patients thus far examined was
signiﬁcantly lower than that of control T cells (Figure 3(a);
1.00 ± 0.28 for the control versus 0.33 ± 0.26 for SLE).
We noticed that the expression level of TCR zeta in each
individual patient showed large variance ranging from 0.002
to0.720.Therefore,weanalyzedtherelationshipbetweenthe
expression level of TCR zeta and the production of IFN-γ or
IL-2. Notably, the production of IFN-γ by SLE T cells was
negatively correlated with the expression level of TCR zeta
when the cells were stimulated through TCR (Figure 3(b)).
The correlation was statistically signiﬁcant (r =− 0.492,P<
.05). On the other hand, the production of IL-2 by SLE
T cells had a strong positive correlation (r = 0.738,P<
.001) with the expression level of TCR zeta (Figure 3(c)). No
signiﬁcant correlation was detected among control T cells
(r = 0.289,P = .530). These results suggest that TCR zeta
plays an important role in the signal transduction through
TCR and that the excessive production of IFN-γ by SLE T
cells is attributed to the reduced expression of TCR zeta.
3.4. Cytokine Production by T Cells upon Polyclonal Stimu-
lation. There are several possibilities that account for the
abnormal production of IFN-γ by SLE T cells: one is that
the signal transduction cascade through TCR is aberrant so
that signals are exaggerated by TCR complex which results in
theinductionoftheexcessiveproductionofIFN-γ.However,
another possibility that the regulatory mechanisms for the
production of IFN-γ are impaired in SLE T cells may not
be ruled out. To test this hypothesis, we employed TPA and
ionomycin,aCa2+ ionophore,for“polyclonalstimulation”of
Tcells,whichbypassTCRanddirectlyactivatetheexpression
of the IFN-γ gene.
SLE T cells produced 5.4 ± 4.6 times as much IFN-γ as
control T cells upon polyclonal stimulation (Figure 4) while
theratiowas2.5±1.4whenthecellswerestimulatedthrough
TCR (Figure 1). In addition, no signiﬁcant correlation was
observed between the expression level of TCR zeta and the
production of IFN-γ in SLE T cells (r =− 0.206, P = .383).
These data suggest that the regulatory mechanism for the
production of IFN-γ was impaired in SLE T cells. On the
other hand, polyclonal stimulation did not cause signiﬁcant
diﬀerence between control and SLE T cells in the production
of IL-2, suggesting that the machinery for the production of
IL-2 was not severely impaired in SLE T cells (Figure 4).
4. Discussion
Several lines of evidence have revealed a crucial role of






















































































































Figure 3: Correlation between the expression levels of TCR zeta and cytokines. The amounts of TCR zeta expressed in control (n = 7) and
SLE (n = 20) T cells were estimated as described in Materials and Methods. The amount of TCR zeta in T cells from individual patient was
normalizedagainsttheaverageofthecontrol.(a)TheaverageexpressionlevelofTCRzetaofSLETcellswascomparedwiththatofcontrolT
cells. Data represent mean ± SD. ∗∗∗P<. 001. (b, c) Scattergrams were depicted between the expression level of TCR zeta and the expression
level of IFN-γ (b) or IL-2 (c).
TCR [23–25]. In addition, not a few investigators including
our group have reported that the expression of TCR zeta
is reduced in SLE T cells [16–20]. In the present study, we
attempted to elucidate the possible mechanism for how the
reducedexpressionofTCRzetaunderliesthedevelopmentof
SLE. To address this issue, we investigated in vitro responses
of SLE T cells against various stimuli. As a response of T
cells,weespeciallyfocusedontheproductionofIFN-γ bythe
cells since IFN-γ induces the diﬀerentiation of B cells which
play a pivotal role in the pathogenesis of SLE by producing
autoantibodies [26]. In order to conﬁrm the stimulation
of T cells, production of IL-2 by the cells was examined
simultaneously.
Stimulation of control and SLE T cells in vitro with
an anti-CD3 antibody, an inducer of signal transduction
through TCR, elicited the production of IFN-γ by the cells.
The production of IFN-γ was abnormally elevated in SLE
T cells as compared with control T cells (Figure 1), as a
consequence of the excessive expression of the IFN-γ gene
(Figure 2). It should be noted that the production of IFN-γ
showed signiﬁcantly negative correlation with the expression
level of TCR zeta (Figure 3(b)), suggesting that the reduced
expression of TCR zeta is at least partly responsible for the
abnormal responses of SLE T cells. Our previous ﬁndings
indicated that several clinical manifestations of SLE patients
were correlated with the expression level of TCR zeta though
no statistically signiﬁcant diﬀerence was observed between
the expression level of TCR zeta and disease activity [16].
These data are consistent with the ﬁndings that (1)
mutations in the zeta gene are relevant to the onset of the
disease in some patients [21, 27–29]a n d( 2 )am u t a t i o n
in ITAM of TCR zeta causes autoimmunity in mice, and T
cells from such mice produced more IFN-γ than wild-type T































Figure 4: Production of IFN-γ and IL-2 by T cells upon stimulation
with TPA and ionomycin. Control T cells (ﬁlled circles) and SLE T
cells(opencircles)wereculturedaccordingtothemethoddescribed
in the legend of Figure 1 except that 1μg/mL of TPA and 0.1μg/mL
of ionomycin were used as stimuli. The amounts of IFN-γ and IL-
2 in the supernatants were measured by ELISA, and the data were
normalized against those for the control. Data represent mean ±
SD. ∗P<. 05.
regulated by CTLA-4, which downregulates activated TCR
through association with phosphorylated TCR zeta [31, 32].
Taken together, we speculate that SLE T cells are devoid
of negative regulation of the expression of IFN-γ because
CTLA-4 is unable to downregulate activated SLE T cells
due to the reduced expression of TCR zeta. A recent report
indicates that the function of CTLA-4 is abnormal in SLE
T cells [33]. Therefore, functional aberration of CTLA-4
andquantitativeabnormalityofTCRzetamaysynergistically
induce abnormal responses of SLE T cells.
We then carried out several experiments to reveal
whether or not the reduced expression of TCR zeta is solely
responsible for the aberration in the production of IFN-γ.
For this purpose, SLE and control T cells were stimulated
with TPA and ionomycin (“polyclonal stimulation”) which
bypass TCR and activate the signal transduction cascade
distal to TCR. If the machinery for the production of IFN-γ
hadbeenintactinSLETcells,theresponsesofthecellswould
have been similar to those of control T cells upon stimula-
tion. The results revealed no signiﬁcant correlation between
the production of IFN-γ and the expression level of TCR
zeta (r =− 0.206, P = .383), probably because polyclonal
stimulation which bypasses TCR was used as a stimulus. The
fact that SLE T cells still produced an abnormally excessive
amountofIFN-γ inspiteofpolyclonalstimulation(Figure 4)
raised the possibility that the regulatory mechanism for the
production of IFN-γ was also impaired in SLE T cells.
In conclusion, our data in the present study suggest
that the regulatory mechanisms not only for the expression
of TCR zeta, but also for the production of IFN-γ,w e r e
impaired in SLE T cells, and these abnormalities may be
involved in the development of SLE. We hope our results as
well as the ﬁndings by others on the abnormalities of SLE
T cells open a new ﬁeld for therapeutic possibilities to treat
SLE.
Abbreviations
RT-PCR: Reverse transcription-polymerase chain
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